Skip to content

Tyrosine-protein phosphatase non-receptor type 23 (PTPN23)

Homo sapiens — UniProt Q9H3S7

Gene: PTPN23Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Tyrosine-protein phosphatase non-receptor type 23 (PTPN23) is a protein from Homo sapiens identified by UniProt accession Q9H3S7, 1636 residues long. MolForge cross-references it against 0 known binders and 101 disease associations.

  • UniProt accession: Q9H3S7; gene symbol PTPN23.
  • Organism: Homo sapiens.
  • Length: 1636 amino acids.
  • Top disease associations (Open Targets): neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity, neurodegenerative disease and Global developmental delay.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameTyrosine-protein phosphatase non-receptor type 23
UniProt accessionQ9H3S7
GenePTPN23
OrganismHomo sapiens
Length1636 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (101)

Diseases linked to this target (Open Targets).

  • neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity · score 0.80
  • neurodegenerative disease · score 0.46
  • Global developmental delay · score 0.41
  • Brain atrophy · score 0.41
  • Intellectual disability · score 0.37
  • complex neurodevelopmental disorder · score 0.37
  • hereditary spastic paraplegia · score 0.26
  • Seizure · score 0.26
  • genetic disorder · score 0.19
  • urinary bladder carcinoma · score 0.16

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9H3S7-F1alphafoldPREDICTED69.54—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q9H3S7.

Amino-acid sequence (1636 residues)

MEAVPRMPMI WLDLKEAGDF HFQPAVKKFV LKNYGENPEA YNEELKKLEL LRQNAVRVPR DFEGCSVLRK YLGQLHYLQS RVPMGSGQEA AVPVTWTEIF SGKSVAHEDI KYEQACILYN LGALHSMLGA MDKRVSEEGM KVSCTHFQCA AGAFAYLREH FPQAYSVDMS RQILTLNVNL MLGQAQECLL EKSMLDNRKS FLVARISAQV VDYYKEACRA LENPDTASLL GRIQKDWKKL VQMKIYYFAA VAHLHMGKQA EEQQKFGERV AYFQSALDKL NEAIKLAKGQ PDTVQDALRF TMDVIGGKYN SAKKDNDFIY HEAVPALDTL QPVKGAPLVK PLPVNPTDPA VTGPDIFAKL VPMAAHEASS LYSEEKAKLL REMMAKIEDK NEVLDQFMDS MQLDPETVDN LDAYSHIPPQ LMEKCAALSV RPDTVRNLVQ SMQVLSGVFT DVEASLKDIR DLLEEDELLE QKFQEAVGQA GAISITSKAE LAEVRREWAK YMEVHEKASF TNSELHRAMN LHVGNLRLLS GPLDQVRAAL PTPALSPEDK AVLQNLKRIL AKVQEMRDQR VSLEQQLREL IQKDDITASL VTTDHSEMKK LFEEQLKKYD QLKVYLEQNL AAQDRVLCAL TEANVQYAAV RRVLSDLDQK WNSTLQTLVA SYEAYEDLMK KSQEGRDFYA DLESKVAALL ERTQSTCQAR EAARQQLLDR ELKKKPPPRP TAPKPLLPRR EESEAVEAGD PPEELRSLPP DMVAGPRLPD TFLGSATPLH FPPSPFPSST GPGPHYLSGP LPPGTYSGPT QLIQPRAPGP HAMPVAPGPA LYPAPAYTPE LGLVPRSSPQ HGVVSSPYVG VGPAPPVAGL PSAPPPQFSG PELAMAVRPA TTTVDSIQAP IPSHTAPRPN PTPAPPPPCF PVPPPQPLPT PYTYPAGAKQ PIPAQHHFSS GIPAGFPAPR IGPQPQPHPQ PHPSQAFGPQ PPQQPLPLQH PHLFPPQAPG LLPPQSPYPY APQPGVLGQP PPPLHTQLYP GPAQDPLPAH SGALPFPSPG PPQPPHPPLA YGPAPSTRPM GPQAAPLTIR GPSSAGQSTP SPHLVPSPAP SPGPGPVPPR PPAAEPPPCL RRGAAAADLL SSSPESQHGG TQSPGGGQPL LQPTKVDAAE GRRPQALRLI ERDPYEHPER LRQLQQELEA FRGQLGDVGA LDTVWRELQD AQEHDARGRS IAIARCYSLK NRHQDVMPYD SNRVVLRSGK DDYINASCVE GLSPYCPPLV ATQAPLPGTA ADFWLMVHEQ KVSVIVMLVS EAEMEKQKVA RYFPTERGQP MVHGALSLAL SSVRSTETHV ERVLSLQFRD QSLKRSLVHL HFPTWPELGL PDSPSNLLRF IQEVHAHYLH QRPLHTPIIV HCSSGVGRTG AFALLYAAVQ EVEAGNGIPE LPQLVRRMRQ QRKHMLQEKL HLRFCYEAVV RHVEQVLQRH GVPPPCKPLA SASISQKNHL PQDSQDLVLG GDVPISSIQA TIAKLSIRPP GGLESPVASL PGPAEPPGLP PASLPESTPI PSSSPPPLSS PLPEAPQPKE EPPVPEAPSS GPPSSSLELL ASLTPEAFSL DSSLRGKQRM SKHNFLQAHN GQGLRATRPS DDPLSLLDPL WTLNKT

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with PTPN23?

The strongest Open Targets associations for PTPN23 are neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity, neurodegenerative disease, Global developmental delay, Brain atrophy and Intellectual disability.

How long is the PTPN23 protein?

The Homo sapiens PTPN23 protein (UniProt Q9H3S7) is 1636 amino acids long.

Browse: Targets: P · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Tyrosine-protein phosphatase non-receptor type 23 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9H3S7
GenePTPN23
OrganismHomo sapiens
Length1636
Binders0
Diseases101
View on UniProt